Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2Article Published on 2022-11-012022-11-15 Journal: Cellular and Molecular Immunology [Category] [DOI] 10.1038/s41423-022-00924-8 PMC 바로가기
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccinationArticle Published on 2022-10-042022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.1010835 PMC 바로가기
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysisArticle Published on 2022-10-012022-11-15 Journal: Clinical and molecular hepatology [Category] [DOI] 10.3350/cmh.2022.0087 PMC 바로가기
Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older peopleResearch article Published on 2022-08-252022-10-05 Journal: Cell Reports Medicine [Category] [DOI] 10.1016/j.xcrm.2022.100739 [Article Type] Research article
Antibody-Mediated Immunogenicity Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Following Priming, Boosting, and Hybrid Immunity: Insights From 11 Months of Follow-up of a Healthcare Worker Cohort in Israel, December 2020-October 2021프라이밍, 부스팅 및 하이브리드 면역에 따른 중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2)에 대한 항체 매개 면역원성: 이스라엘 의료 종사자 집단의 11개월 추적 관찰에서 얻은 통찰력, 2020년 12월-2021년 10월Article Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciac212 PMC 바로가기 [Article Type] Article
Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in JapanObservational Study Published on 2022-08-012022-10-05 Journal: International Journal of Molecular Sciences [Category] [DOI] 10.1016/j.jtho.2022.05.015 PMC 바로가기 [Article Type] Observational Study
Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant동종 골수 이식 후 2년 미만의 환자에서 1차 COVID-19 예방 접종에 대한 체액 및 세포 반응 손상Article Published on 2022-08-012022-09-11 Journal: British Journal of Haematology [Category] [DOI] 10.1111/bjh.18312 PMC 바로가기 [Article Type] Article
Routine SARS-CoV-2 vaccination for all children모든 어린이를 위한 정기 SARS-CoV-2 예방 접종Review Published on 2022-08-012022-09-11 Journal: Immunological reviews [Category] [DOI] 10.1111/imr.13108 PMC 바로가기 [Article Type] Review
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trialCOVID-19 회복기 참가자에 대한 FINLAY-FR-1A 백신의 안전성 및 면역원성: 공개 라벨 2a상 및 이중 맹검, 무작위 배정, 위약 대조, 2b상, 심리스, 임상 시험Clinical Trial Published on 2022-08-012022-09-11 Journal: The Lancet. Respiratory Medicine [Category] [DOI] 10.1016/S2213-2600(22)00100-X PMC 바로가기 [Article Type] Clinical Trial
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome원발성 항인지질 증후군 환자에서 SARS-CoV-2 백신 후 면역원성, 안전성 및 항인지질항체Article Published on 2022-07-012022-09-12 Journal: Lupus [Category] [DOI] 10.1177/09612033221102073 PMC 바로가기 [Article Type] Article